Molecular epidemiology of CTX-M-producing Escherichia coli in the Calgary Health Region: emergence of CTX-M-15-producing isolates
- PMID: 17283198
- PMCID: PMC1855502
- DOI: 10.1128/AAC.01377-06
Molecular epidemiology of CTX-M-producing Escherichia coli in the Calgary Health Region: emergence of CTX-M-15-producing isolates
Abstract
A study was designed to describe the molecular epidemiology of CTX-M-producing Escherichia coli over a 6-year period (2000 to 2005) in a large well-defined Canadian region with a centralized laboratory system. Molecular characterization was done by isoelectric focusing, PCR, and automated sequencing, while genetic relatedness was determined by pulsed-field gel electrophoresis with XbaI. Of the 552 viable extended-spectrum beta-lactamase-producing E. coli isolates isolated, 354 (64%) were positive for blaCTX-M genes associated with ISEcp1; 211 produced CTX-M-14, 128 produced CTX-M-15, 5 produced CTX-M-2, 4 produced CTX-M-3, 4 produced CTX-M-24, and 2 produced CTX-M-27. CTX-M-positive isolates were significantly more resistant to the fluoroquinolones than CTX-M-negative isolates, while CTX-M-15 producers were more likely to be resistant to gentamicin and tobramycin. There was a predominance of CTX-M-14 during the first 4 years of the study period, with community outbreaks associated with cluster 14A during 2000, 2001, and 2003. A substantial increase in CTX-M-15 producers occurred during the last 18 months and was due to clusters 15A and 15AR (where AR indicates related to A) in the hospital and nursing home sectors. Our results demonstrate that the persistence and dissemination of CTX-M genes among E. coli populations in larger geographic health care regions is dynamic, with the continuous emergence of clonally related CTX-M-15. This study illustrates the importance of molecular surveillance in tracking CTX-M-producing E. coli strains in the community and investigating their influx into hospitals.
Figures


Similar articles
-
Molecular characteristics of extended-spectrum beta-lactamase-producing Escherichia coli from the Chicago area: high prevalence of ST131 producing CTX-M-15 in community hospitals.Int J Antimicrob Agents. 2010 Jul;36(1):19-23. doi: 10.1016/j.ijantimicag.2010.02.016. Epub 2010 Mar 31. Int J Antimicrob Agents. 2010. PMID: 20359869
-
Spread of extended-spectrum beta-lactamase CTX-M-producing escherichia coli clinical isolates in community and nosocomial environments in Portugal.Antimicrob Agents Chemother. 2007 Jun;51(6):1946-55. doi: 10.1128/AAC.01412-06. Epub 2007 Mar 19. Antimicrob Agents Chemother. 2007. PMID: 17371815 Free PMC article.
-
Characteristics of infections caused by extended-spectrum β-lactamase-producing Escherichia coli from community hospitals in South Africa.Diagn Microbiol Infect Dis. 2011 Apr;69(4):449-53. doi: 10.1016/j.diagmicrobio.2010.11.011. Diagn Microbiol Infect Dis. 2011. PMID: 21396544
-
Epidemiology of Cefotaxime-Hydrolysing β-Lactamase-Producing Escherichia coli in Children with Diarrhoea Reported Globally between 2012 and 2022.Microorganisms. 2024 Jan 15;12(1):171. doi: 10.3390/microorganisms12010171. Microorganisms. 2024. PMID: 38257997 Free PMC article. Review.
-
Population-based epidemiology of Escherichia coli ST1193 causing blood stream infections in a centralized Canadian region.Eur J Clin Microbiol Infect Dis. 2021 Nov 9. doi: 10.1007/s10096-021-04373-5. Online ahead of print. Eur J Clin Microbiol Infect Dis. 2021. PMID: 34750697 Review.
Cited by
-
Gram-negative bacteria that produce carbapenemases causing death attributed to recent foreign hospitalization.Antimicrob Agents Chemother. 2013 Jul;57(7):3085-91. doi: 10.1128/AAC.00297-13. Epub 2013 Apr 22. Antimicrob Agents Chemother. 2013. PMID: 23612195 Free PMC article.
-
Prevalence of antimicrobial-resistant pathogens in Canadian hospitals: results of the Canadian Ward Surveillance Study (CANWARD 2008).Antimicrob Agents Chemother. 2010 Nov;54(11):4684-93. doi: 10.1128/AAC.00469-10. Epub 2010 Aug 30. Antimicrob Agents Chemother. 2010. PMID: 20805395 Free PMC article.
-
Changing epidemiology of infections due to extended spectrum beta-lactamase producing bacteria.Antimicrob Resist Infect Control. 2014 Mar 25;3(1):9. doi: 10.1186/2047-2994-3-9. Antimicrob Resist Infect Control. 2014. PMID: 24666610 Free PMC article.
-
The continuing challenge of ESBLs.Curr Opin Pharmacol. 2007 Oct;7(5):459-69. doi: 10.1016/j.coph.2007.08.003. Epub 2007 Sep 17. Curr Opin Pharmacol. 2007. PMID: 17875405 Free PMC article. Review.
-
Global fluoroquinolone resistance epidemiology and implictions for clinical use.Interdiscip Perspect Infect Dis. 2012;2012:976273. doi: 10.1155/2012/976273. Epub 2012 Oct 14. Interdiscip Perspect Infect Dis. 2012. PMID: 23097666 Free PMC article.
References
-
- Babic, M., A. M. Hujer, and R. A. Bonomo. 2006. What's new in antibiotic resistance? Focus on β-lactamases. Drug Resist. Update 9:142-156. - PubMed
-
- Bin, C., W. Hui, Z. Renyuan, N. Yongzhong, X. Xiuli, X. Yingchun, Z. Yuanjue, and C. Minjun. 2006. Outcome of cephalosporin treatment of bacteremia due to CTX-M-type extended-spectrum β-lactamase-producing Escherichia coli. Diagn. Microbiol. Infect. Dis. [E-pub ahead of print.] - PubMed
-
- Bonnet, R., C. Recule, R. Baraduc, C. Chanal, D. Sirot, C. De Champs, and J. Sirot. 2003. Effect of D240G substitution in a novel ESBL CTX-M-27. J. Antimicrob. Chemother. 52:29-35. - PubMed
-
- Bouallegue-Godet, O., Y. Ben Salem, L. Fabre, M. Demartin, P. A. Grimont, R. Mzoughi, and F. X. Weill. 2005. Nosocomial outbreak caused by Salmonella enterica serotype Livingstone producing CTX-M-27 extended-spectrum β-lactamase in a neonatal unit in Sousse, Tunisia. J. Clin. Microbiol. 43:1037-1044. - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials